AnaptysBio (Rights to Imsidolimab) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
AnaptysBio (Rights to Imsidolimab) General Information
Description
Drug rights for rare skin disorder.
Contact Information
Corporate Office
- San Diego, CA
- United States
Corporate Office
- San Diego, CA
- United States
AnaptysBio (Rights to Imsidolimab) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AnaptysBio (Rights to Imsidolimab) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
AnaptysBio (Rights to Imsidolimab) FAQs
-
Where is AnaptysBio (Rights to Imsidolimab) headquartered?
AnaptysBio (Rights to Imsidolimab) is headquartered in San Diego, CA.
-
What industry is AnaptysBio (Rights to Imsidolimab) in?
AnaptysBio (Rights to Imsidolimab)’s primary industry is Buildings and Property.
-
Is AnaptysBio (Rights to Imsidolimab) a private or public company?
AnaptysBio (Rights to Imsidolimab) is a Private company.
-
What is AnaptysBio (Rights to Imsidolimab)’s current revenue?
The current revenue for AnaptysBio (Rights to Imsidolimab) is .
-
Who are AnaptysBio (Rights to Imsidolimab)’s investors?
AnaptysBio has invested in AnaptysBio (Rights to Imsidolimab).
-
When was AnaptysBio (Rights to Imsidolimab) acquired?
AnaptysBio (Rights to Imsidolimab) was acquired on 26-Feb-2026.
-
Who acquired AnaptysBio (Rights to Imsidolimab)?
AnaptysBio (Rights to Imsidolimab) was acquired by Vanda Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process